Vitamin E markets in the United States posted mixed dynamics, ending with a retreat but a firmer near-term tone into April. Early weakness gave way to momentum-driven buying from nutraceutical distributors in mid-month, while demand from supplements, functional foods, and infant formula lifted offers. Elevated energy benchmarks and regional transit disruptions added upward pressure on supplier quotations, while steady feedstock flows moderated gains. The tone improved as Q1 wellness buying and import-dependent buyers' inventory concerns supported a cautious, bullish stance for the near term. Demand remained strongest from dietary supplements and nutraceuticals, along with functional foods and infant formula producers, underpinning premiums for Vitamin E 50% CWS FOB Illinois. Domestic production covers a minority of demand, amplifying import dependence. On the supply side, higher crude and gas benchmarks increased production and logistics costs, reinforcing firmer offers, while steady inputs like soybean oil distillates capped upside. The outlook remains tilted toward further upside, though substitution risk and softer macro sentiment could temper rallies.
